Ares Financial Consulting’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$154K Buy
1,063
+33
+3% +$4.56K 0.11% 104
2026
Q2
$132K Buy
1,030
+53
+5% +$6.2K 0.1% 115
2026
Q1
$118K Buy
977
+364
+59% +$42K 0.09% 112
2025
Q4
$64.5K Buy
+613
New +$57.5K 0.06% 137

Other funds holding MRK

Ares Financial Consulting's MRK Position: Q3 2026 in Review

Ares Financial Consulting increased its Merck (MRK) stake by 3.2% in Q3 2026, buying an estimated $4.56K and bringing the position to 1,063 shares worth $154K. The position accounts for 0.11% of the portfolio, ranked #104.

Ares Financial Consulting first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,411 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Ares Financial Consulting held 1,063 shares of Merck worth $154K as of Q3 2026.
  • Ares Financial Consulting bought 33 Merck shares in Q3 2026, an estimated $4.56K.
  • Merck made up 0.11% of Ares Financial Consulting's portfolio in Q3 2026, its #104 holding.
  • Ares Financial Consulting first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 3,411 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.